Sotrovimab

Published

dm+d

40384311000001103

Lactation Safety Information

No published evidence for use in breastfeeding
Negligible levels anticipated in milk, and very limited absorption from the infant’s gastro-intestinal tract expected due to the drug’s properties. Therefore, infant side effects are unlikely.
Theoretically, absorption may be increased slightly in the neonatal period due to increased gastrointestinal permeability.
Monitor the infant for adequate feeding and hypersensitivity reactions
Breastfeeding can continue with COVID-19 infection
7 December 2021